Superiority of carboplatin monochemotherapy over carboplatin-based polychemotherapy in ovarian cancer

European Journal of Gynaecological Oncology

Volumn 18, Issue 5, 1997, Pages 420-425

  Athanassiou, A ^a   Varthalitis, J ^a   Tsavaris, N ^a,b   Dimitriadis, M ^a   Moutzouridis, G ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; IFOSFAMIDE; MESNA; VINCRISTINE;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEMATURIA; HUMAN; HYPOTENSION; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG FIBROSIS; NEUROTOXICITY; OVARY CANCER; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SECOND LOOK SURGERY; SKIN TOXICITY; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARBOPLATIN; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; OVARIAN NEOPLASMS; VINCRISTINE;

EID: 0030754686     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Calvet A. H., Harland S. J., Newell D. R., Siddik Z. H., Jones A. C., McElwain T. J., Raju S., Witshaw E., Smith I. E , Baker J. M., Peckham M. J., Harrap K. R.: "Early clinical studies with cis-diammine-1.1 cyclobutane dicarboxylate platinum II". Cancer Chemother. Pharmacol., 1982, 9, 140.
2. Evans B. D., Raju K. S., Calvert A. H., Harland S. J., Wiltshaw E.: "Phase II study of JM8: a new platinum analog in advanced ovarian carcinoma". Cancer Treat. Rep., 1983, 67, 997.
3. Wiltshaw E.: "Ovarian trials at the Royal Marsden". Cancer Treat. Rev., 1981, 12, 67.
4. Ten Bokkel Huinink W. W., van der Burg M. E., van Oosterom A. T., Neijt J. P., George M., Guastalla J. P., Veenhof C. H., Rotmensz N., Dalesio O., Vermorken J. B.: "Carboplatin in combination therapy for ovarian cancer". Cancer Treat. Rev., 1988, 15, 9.
5. Adams M., Kerby I. J., Rocker J., Evans A., Johansen K., Franks C. R.: "A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The swons gynaecological cancer group". Acta Oncol., 1989, 25, 57.
6. Gurney H., Crowther D., Anderson H., Murphy D., Prendiville J., Ranson M., Mayor P., Swindell R., Buckley C. H., Tindall V. R.: "Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma". Ann. Oncol., 1990, 1, 427
7. Bruhl P., Bunther U., Hoefer-Janker H.: "Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumors". Int. J Clin. Pharmacol., 1976, 14, 29.
8. Yazigi R., Wild R., Madrid J.: "Ifosfamide treatment of advanced ovarian cancer". Obstet. Gynecol., 1984, 63, 163.
9. Burkert H.: "Ifosfamide. European perspective" Semin. Oncol., 1982, 9 (1), 28.
10. Green J. A., Slater A. J.: "A study of cis-platin and ifosfamide in alkylating agent resistant ovarian cancer" Gynecol. Oncol., 1989, 32, 233.
11. Goldin A.: "Ifosfamide in experimental tumor systems". Semin. Oncol., 1982, 9, 14.
12. th edition, New York, McGraw-Hill, 1983.
13. Kaplan H. L., Meier R.: "Non-parametric estimations from incomplete observations". J. Am. Stat. Assoc., 1958, 53, 457.
14. Mantel N.: "Evaluation of survival data and two new rank order statistics arising in its consideration". Cancer. Chemother. Rep., 1966, 50, 163.
15. Machin D., Campell M. J.: "Statistical tables for the design of clinical trials". Oxford, Blackwell, 1987, 79.
16. Louie K. G., Ozols R. F., Myers C. E., Ostchega Y., Jenkins J., Howeer D., Young R. C.: "Long-term results of a cis-platin containing combination chemotherapy regimen for treatment of advanced ovarian carcinomas". J. Clin. Oncol., 1986, 4, 1579
17. Wiltshaw E., Evans B., Rustin G., Gilbey E., Baker J., Barker G.: "A prospective randomized trial comparing high dose cisplatin with low dose cisplatin and chloramboucil in advanced ovarian carcinoma". J. Clin. Oncol., 1986, 4, 722.
18. Rankin E. M., Mill L., Kaye S. B., Atkinson R., Cassidy L., Cordine J., Cruickshank D , Davis J., Duncan I. D;, Fullerton W.: "A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer". Br. J Cancer, 1992, 65, 275.
19. Lorusso V, Catino A., Leone B., Rabinovich M., Gargano G., Paradiso A., De Lena M.: "Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study". J. Clin. Oncol., 1993, 11, 1952.
20. Gallagher C. J., Wiltshaw E., Coleman R. E., Harper P. G.: "A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancer". Cancer Chemother. Pharmacol., 1989, 24, 54.
21. Wiltshaw E., Perren T. J., Fryatt I. D., Blake P. R., Harper P., Slevin M.: "Carboplatin and ifosfamide in ovarian cancer phase II and III trials London gynaecological oncology group" Cancer Chemother. Pharmacol., 1990, 26, 48.
22. Perren T. J , Wiltshaw E., Harper P., Slevin M., Stein R., Tan S., Gore M., Fryatt I. J., Blake P R.: "A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stages III epithelial ovarian carcinoma". Br. J. Cancer, 1993, 68, 1190.
23. Lund B., Hansen O. P., Hansen H. H.: "High-dose platinum consisting of combined carboplatin and cisplatin in previously intreated ovarian cancer patients with residual disease". J Clin. Oncol., 1989, 7, 1469.
24. Lund B., Hansen M., Hansen O. P., Hansen H. H.: "Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease". J. Clin. Oncol., 1990, 8, 1226.
25. Neijt J. P., ten Bokkel Humink W. W., van der Burg M. E. L., van Oosteron A. T., Willemse P. H. B., Heintz A. P. M., van Lent M., Trimbos J. B., Bouma J , Vermorken J. B., van Huwelinger J. C.: "Randomized trials comparing two combination chemotherapy regimens (CHAP-5 vs CP) in advanced ovarian carcinoma". J. Clin. Oncol., 1987, 5, 1157.
26. Gruppo Interregionale Cooperativo Oncologia Ginecologica. "Randomized comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxurubicin/cisplatin in advanced ovarian cancer". Lancet, 1987, 2, 353.
27. Omura G. A., Bundy B. N., Berek J. S., Curry S., Delgado G., Mortel R.: "Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a gynecologic oncology group study". J. Clin. Oncol., 1989, 7, 457.
28. Hatae M., Onishi Y., Maeda Y., Nakamura T., Maeda T., Wada T.: "Consesus and new development in epithelial ovarian chemotherapy in 1995". Gan to Kagaku Ryoho, 1995, 22, 1182.
29. Colombo N., Maggioni A., Vignali M., Parma G., Mangioni C.: "Options for primary chemotherapy in advanced ovarian cancer: the European perspective". Gynecol. Oncol., 1994, 55, 108.
30. Williams C. J., Stewart L. A., Parmar M. K., Guthrie D.: "An overview of chemotherapy in advanced ovarian carcinoma FIGO III and IV". Proc. ASCO: A 622, 1990.